<bill session="107" type="hr" number="26" updated="2013-07-14T18:56:44-04:00">
  <state datetime="2001-01-31">REFERRED</state>
  <status>
    <introduced datetime="2001-01-31"/>
  </status>
  <introduced datetime="2001-01-31"/>
  <titles>
    <title as="introduced" type="official">Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.</title>
  </titles>
  <sponsor id="400525"/>
  <cosponsors>
    <cosponsor id="400047" joined="2001-03-07"/>
    <cosponsor id="400121" joined="2001-01-31"/>
    <cosponsor id="400263" joined="2001-03-07"/>
    <cosponsor id="400513" joined="2001-03-07"/>
    <cosponsor id="400268" joined="2001-02-14"/>
    <cosponsor id="400329" joined="2001-07-11"/>
    <cosponsor id="400387" joined="2001-03-07"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2001-01-31">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2001-02-01">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E98"/>
    </action>
    <action datetime="2001-02-14">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Committee on Energy and Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Latin America"/>
    <term name="Mexico"/>
    <term name="Prescription pricing"/>
    <term name="Price policy"/>
  </subjects>
  <amendments/>
  <summary>1/31/2001--Introduced.
Expresses the sense of the House of Representatives that the cost disparity between identical prescription drugs sold in the United States, Canada, and Mexico should be reduced or eliminated.</summary>
</bill>
